Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
Plank, J; Bock, GM.
Drug treatment of type 2 diabetes.
Wien Med Wochenschr. 2003; 153(21-22):452-458
Doi: 10.1007/s10354-003-0034-z
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Treiber Gerlies
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Diabetes mellitus and its complications constitute a major health problem in modern societies. The disease affects approximately 5% of the adult population in western countries. The underlying process of the metabolic disorder is a defect in insulin secretion, insulin action, or both. Weight reduction, calorie restriction and patient education remain the cornerstones of the management of type 2 diabetes. When lifestyle modification fails to maintain adequate glycaemic control, insulin or oral hypoglycemic agents are typically used to manage the disease. The currently available five classes of oral agents differ in mechanism and duration of action, the degree to which they lower blood glucose and their side-effect profile. For most of these antiglycaemic agents, there is a lack of evidence on the effects on long-term complications. Only metformin has clearly proved that it can reduce mortality in obese patients with type 2 diabetes. Human insulin reduces acute and long-term mortality in patients with CVD. Furthermore, intensive treatment either with insulin or sulfonylurea has proved that it can prevent microvascular complications in type 2 diabetes. Additional randomized controlled trails assessing hard clinical endpoints are needed to better inform patients and enable physicians to establish optimal treatment strategies.
- Find related publications in this database (using NLM MeSH Indexing)
- Administration, Oral -
- Cause of Death -
- Diabetes Complications -
- Diabetes Mellitus - drug therapy Diabetes Mellitus - mortality
- Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - drug therapy Diabetes Mellitus, Type 2 - mortality
- Humans -
- Hypoglycemic Agents - adverse effects Hypoglycemic Agents - classification Hypoglycemic Agents - therapeutic use
- Long-Term Care -
- Metformin - adverse effects Metformin - therapeutic use
- Obesity -
- Randomized Controlled Trials as Topic -
- Survival Analysis -